학술논문
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
Document Type
Article
Author
Gordon, M.J.; Strati, P.; Lee, H.J.; Hagemeister, F.B.; Westin, J.R.; Samaniego, F.; Claret, L.; Averill, B.; Ibanez, K.; Fayad, L.E.; Flowers, C.R.; Green, M.R.; Davis, R.E.; Neelapu, S.S.; Fowler, N.H.; Nastoupil, L.J.; Feng, L.; Marques-Piubelli, M.L.; Parra Cuentas, E.R.; Solis-Soto, L.M.; Vega Vazquez, F.; Ma, W.; Wang, J.
Source
In: Cancer . (Cancer, 15 March 2024, 130(6):876-885)
Subject
Language
English
ISSN
10970142
0008543X
0008543X